Insmed's promising drug pipeline includes Brensocatib and Arikayce. See why INSM stock is a strong pick with multi-billion ...

Kuro Oncology and partner Kyowa Kirin are on track for an NDA submission for ziftomenib in the second quarter of this year.

Brensocatib is a small molecule, oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP1) being developed by Insmed for the treatment of patients with bronchiectasis, chronic rhinosinusitis without ...

Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company with a market capitalization of $5.2 billion focused on developing novel therapies for central nervous system (CNS) disorders, has ...

The UK Nuclear Decommissioning Authority (NDA) honoured five award winners earlier in January at its tenth supply chain event ...

Compensation is coming for two Saskatchewan families who went public about their treatment at a Mexican resort where they say staff pressured them to sign non-disclosure agreements to prevent bad ...

President Donald Trump signed an executive order Monday directing the United States to again withdraw from the landmark Paris climate agreement. The pact is aimed at limiting long-term global ...

There’s just one hitch: they want you sign an NDA (Nondisclosure agreement). You’re not a lawyer, you’re an actor; so what to do? If you’re at all concerned, the performer’s union Equity ...

39 total non-English hits have reached the top 10, including 13 by Bad Bunny. By Xander Zellner Non-English-language music has a long history on Billboard’s charts. While, naturally, the U.S ...

MUMBAI: The ongoing dispute within the Kirloskar family has intensified, with Kirloskar Brothers Ltd (KBL) seeking intervention in the Securities Appellate Tribunal (SAT) in an appeal filed by ...

As the company faces criticism for its decision last year to not renew insurance policies for 72,000 property owners in California, State Farm has nixed plans to run a commercial during this year ...